Early buyers will receive 10% customization on this report.
The key factors driving the growth of this market include increasing incidence of sports injuries, continuous influx of new products & treatment modalities, and developments in the field of regenerative medicine. However, the high cost of orthopedic implants may hinder the growth of this market to a certain extent.
By product, the body reconstruction products segment to account for the largest share of the market in 2017
On the basis of product, the sports medicine market is broadly segmented into body reconstruction products, body support & recovery products, and accessories. In 2017, the body reconstruction products segment is expected to account for the largest share of the market owing to the increasing use of fracture and ligament devices and arthroscopy devices for minimally invasive surgeries.
The body reconstruction products segment is further categorized into implants, fracture & ligament repair devices, arthroscopy devices, prosthetics, and orthobiologics. In 2017, the fracture & ligament repair devices segment is expected to account for the largest share of the market. The body support & recovery products segment is further divided into braces and supports, compression clothing, and physiotherapy equipment.
In 2017, the braces and supports segment is expected to account for the largest share of the body support & recovery products market. The physiotherapy equipment segment is further categorized into thermal therapy, electrostimulation, and other therapies.
By application, the knee injuries segment to hold the largest market share in 2017
Based on application, the market is segmented into shoulder, foot and ankle, elbow and wrist, back and spine, hip and groin, knee, and other injuries (head, face, and finger injuries). In 2017, the knee injuries segment is estimated to command the largest share of the sports medicine market. Growth in the knee injuries segment can be attributed to the increasing participation in sports like football and basketball at a younger age, resulting in high prevalence of knee injuries.
North America to dominate the market in 2017
In 2017, North America is expected to account for the largest share of the sports medicine market, followed by Europe, Asia Pacific (APAC), and the Rest of the World (Latin America and the Middle East & Africa). In the US, the increasing popularity of sports & physical activity and efforts to create awareness for the management of sports are the major growth factors. In Canada, market growth is mainly driven by continued government support for sports medicine.
The sports medicine market in several APAC countries, particularly China, Japan, India, and Australia, is expected to witness high growth during the forecast period. This can be attributed to the influx of international players, government initiatives to promote sports medicine, and collaborations for sports medicine research are some of the major factors boosting market growth in Asia Pacific.
The key players in the global sports medicine market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), CONMED (US), Zimmer Biomet. (US), Breg (US), DJO Global (US), Mueller Sports, (US), Wright Medical Group (US), Medtronic (Ireland), RTI Surgical (US), and Performance Health International (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: